|
|
Professor Lee M. Ellis, MD
Professor of Surgery, and Molecular & Cellular Oncology, The William C. Liedtke, Jr. Chair in Cancer Research, The University of Texas MD Anderson Cancer Center
SWOG Vice Chair for Translational Medicine
Houston, Texas, United States |
|
|
Biography: |
|
|
Lee M. Ellis, MD, completed a surgical oncology fellowship at the M. D. Anderson Cancer Center (MDACC), where he has been on the faculty since 1993 leading a clinical practice focused on colorectal cancer. Dr. Ellis has expertise in the area of angiogenesis and cell signaling in gastrointestinal malignancies. He has served on numerous NIH study sections and is a consultant to the NCI. Dr. Ellis serves on numerous editorial boards, including being a Deputy Editor of JAMA Oncology. Dr. Ellis has co-authored over 230 peer-reviewed publications, 110 invited reviews and editorials, three books, and 30 book chapters. In 2012, he co-authored an important editorial in Nature on data reproducibility. Dr. Ellis has served in leadership roles in the major cancer societies (SSO, ASCO, AACR, and Keystone Scientific Symposium). He was Chair of the 2007 GI Cancers Symposium and was Co-Chair of the 2009 and 2011 AACR annual meetings. From 2008-2012, Dr. Ellis served as Chair, Ad Interim, Department of Cancer Biology at MDACC. He served as Co-Director for the AACR/ASCO Workshop on Methods in Clinical Cancer Research from 2010-2012 and is co-director of the FLIMS Clinical Trial Workshop. In May 2013, he became Vice Chair for Translational Medicine, SWOG. Dr. Ellis served as chair of the ASCO Cancer Research Committee (2012-2013) where he led an effort to provide guidelines regarding meaningful clinical outcomes for patients on clinical trials (JCO, 2014). Dr. Ellis was inducted as a Fellow of ASCO in 2014. |
|
Session: |
|
|
20th November 2015 (Friday) |
|
17:45-18:15 |
|
|
Plenary Section I |
Research Integrity and the Need for a Culture Change in Academic Medicine |
|
|
|